Undernutrition and hyperandrogenism during pregnancy: Role in programming of cardiovascular disease and infertility.
Francesca MossaKeith E LathamJames J IrelandAlmudena Veiga-LopezPublished in: Molecular reproduction and development (2019)
Maternal nutritional status programs the development of several systems in female offspring, with effects that depend on the severity, duration, and window of development when the nutritional perturbation is imposed. On the basis of the developmental origins of health and disease concept, we hypothesize that gestational low caloric intake may induce maternal subclinical hyperandrogenism during early pregnancy and compromise cardiovascular health and fertility in the female offspring. To examine this possibility, a literature search for human and animal studies was conducted using two electronic databases, PubMed and Cochrane until April 2019 to address the following questions: (a) Do androgens have a developmental role in cardiovascular and ovarian development? (b) Is excess maternal testosterone linked to cardiovascular disease and infertility? and (c) Could early pregnancy undernutrition enhance maternal androgen production and compromise health and fertility in female offspring? The observations reviewed, establish a potential causative link between maternal undernutrition and subclinical hyperandrogenism with hypertension and reduced ovarian reserve in the progeny. Further studies in appropriate models are needed to better understand whether low energy intake and subclinical maternal hyperandrogenism during early pregnancy can negatively affect the health of the female offspring.
Keyphrases
- birth weight
- cardiovascular disease
- pregnancy outcomes
- polycystic ovary syndrome
- public health
- weight gain
- healthcare
- high fat diet
- mental health
- gestational age
- blood pressure
- systematic review
- endothelial cells
- physical activity
- risk assessment
- machine learning
- human health
- health promotion
- deep learning
- young adults
- preterm birth
- case control
- skeletal muscle
- induced pluripotent stem cells
- replacement therapy